Revolutionising healthcare through improving diagnostics
Scientists from Randox Laboratories will measure the levels of the protein biomarkers in urine and blood collected from the patients recruited to HaBio. The scientists analysing the samples from the patients will not know any details about the individual patients. The samples will be anonymised. All patient data will be stored securely in the Northern Ireland Cancer Trial Centre.
Randox Laboratories Ltd is a leading global developer and manufacturer of diagnostic solutions. Established in 1982, Randox now employs approximately 1000 people, including over 200 research scientists, and has 25 international offices as well as distribution agreements in over 130 countries worldwide.
Randox offers a large portfolio of products which include the innovative multi-analyte Biochip Array Technology (BAT), a wide range of Quality Management Solutions including the manufacture of internal quality controls, international EQA programmes and its recently released 24.7 web based data management software. This is in addition to a series of clinical chemistry analysers and world class routine and novel high quality reagents. Randox is also widely renowned for its OEM manufacturing capability, manufacturing for some of the world’s largest diagnostic companies.
Success at Randox is built on the philosophy that ‘we exist and expand through our customers’ and 20% of total annual revenue is reinvested back into research and development. Five times winner of the Queen’s Award for Enterprise and awarded Product Innovation Award at the Manufacturing Excellence Awards 2009, Randox continues to provide the highest quality, most accurate and cost-effective products and services.